Verano HoldingsVRNOD +0.19%65 Market Cap is $398.8 Mil as of Jun. 24, 2026. GuruFocus rates VRNOD with a GF Score™ of 65/100 and a GF Value™ of $7.76 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 1,023 Drug Manufacturers companies, Verano Holdings ranks better than 58.75% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Verano Holdings's share price for the quarter that ended in Mar. 2026 was $5.55. Verano Holdings's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 72.9 Mil. Therefore, Verano Holdings's market cap for the quarter that ended in Mar. 2026 was $404.4 Mil.
Verano Holdings's quarterly market cap
declined
from Sep. 2025 ($500.8 Mil) to Dec. 2025 ($457.7 Mil) and
declined
from Dec. 2025 ($457.7 Mil) to Mar. 2026 ($404.4 Mil).
Verano Holdings's annual market cap
declined
from Dec. 2023 ($1,541.5 Mil) to Dec. 2024 ($446.6 Mil) but then
increased
from Dec. 2024 ($446.6 Mil) to Dec. 2025 ($457.7 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Verano Holdings's Enterprise Value for Today is $820.2 Mil.
Verano Holdings (OTCPK:VRNOD) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Verano Holdings Market Cap Related Terms
Verano Holdings Market Cap Historical Data
* Premium members only.
The historical data trend for Verano Holdings's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Verano Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Verano Holdings Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Verano Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where Verano Holdings's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Verano Holdings's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Verano Holdings (VRNOD) has a Market Cap of $398.8 Mil as of Jun. 24, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Verano Holdings and its competitors. According to the industry distribution chart, Verano Holdings ranks #422 out of 1023 companies in the Drug Manufacturers industry, placing it in the top 41.3%.
Is Verano Holdings' Market Cap too high?
Verano Holdings' current Market Cap is $398.8 Mil. The Drug Manufacturers industry median Market Cap is 207.38. Verano Holdings' value of $398.8 Mil is 92.3% above this industry median. Based on the distribution chart, Verano Holdings ranks #422 out of 1023 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Verano Holdings has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Verano Holdings' Market Cap compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Verano Holdings ranks #422 out of 1023 companies for Market Cap. This puts Verano Holdings in the upper half of its industry. The industry median Market Cap is 207.38. Verano Holdings' value of $398.8 Mil is 92.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 207.38, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Verano Holdings's current Market Cap of $398.8 Mil is 92.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Verano Holdings and its competitors. For the Drug Manufacturers industry, the median Market Cap is 207.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Verano Holdings's current Market Cap is $398.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Verano Holdings stock overvalued right now?
Based on GuruFocus' analysis, Verano Holdings (VRNOD) is currently considered Possible Value Trap. The stock's GF Value™ is $7.76, compared to a current price of $5.31 — trading 31.6% below its estimated fair value. The current Market Cap is $398.8 Mil and 92.3% above the Drug Manufacturers industry median of 207.38. Verano Holdings' overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Verano Holdings (VRNOD), the current Market Cap is $398.8 Mil as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Verano Holdings (VRNOD) Overvalued in 2026?
Based on GuruFocus' analysis, Verano Holdings stock appears to be undervalued.
The current stock price of $5.31 is trading 31.6% below its estimated GF Value™ of $7.76.
GuruFocus considers Verano Holdings to be Possible Value Trap.
Key valuation signals for VRNOD:
Market Cap: $398.8 Mil
GF Value™: $7.76 vs. price of $5.31 (31.6% below fair value)
Industry Position: 92.3% above the Drug Manufacturers median (#422 of 1023)
No single metric tells the full story. See the VRNOD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Verano Holdings Corp is a vertically integrated, multi-state cannabis operator in the United States. The company operates through cultivation (wholesale) and retail segments. Its consumer brands include Encore, Avexia, MUV, Savvy, BITS, and Verano, while its retail dispensaries operate under brands such as Zen Leaf and MUV. The company derives the majority of its revenue from the retail segment.
65GF Score
Get the complete analysis for VRNOD
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VRNOD has been successfully added to your 
